Dysport

June 26, 2017June 26, 2017

MS News That Caught My Eye This Week: Brain Scans, Spasticity, Tecfidera Study and Cigarettes

Columns, The MS Wire - A Column by Ed Tobias

In case you missed them, here are some news stories that appeared in MS News Today that caught my eye over the past week. **** Harvard Study Finds No Link ... Read more

June 19, 2017June 19, 2017

FDA Expands Dysport’s Approval for Treatment of Lower Limb Spasticity in Adults

News

The U.S. Food and Drug Administration (FDA) has expanded approval of Dysport (abobotulinumtoxinA) for treatment of spasticity in adults, a condition that affects many people in the United States, ... Read more

December 8, 2014December 12, 2014

Ipsen Biopharmaceuticals Announces FDA To Review sBLA For Dysport® As Treatment For Upper Limb Spasticity

Multiple Sclerosis News, News

Ipsen Biopharmaceuticals, Inc announced that the United States Food and Drug Administration (FDA) has agreed to review the supplemental Biologics License Application (sBLA) for Dysport® (abobotulinumtoxinA) to treat upper limb spasticity, a condition that ... Read more

Pin It on Pinterest